https://www.dukehealth.org/clinical-trials/directory/pro00104852
D2C7 + Anti-CD40 for Malignant... | Clinical Trials at Duke
*The study is currently open only to study subgroup #3. Subgroup #3 is the portion of the study when the study drug combination is... | View the details of...
clinical trialsantimalignantduke